About Galmed Pharmaceuticals Ltd. (adapted from Galmed Pharmaceuticals Ltd. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel, once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing our proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs.

This description is adapted from Galmed prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.